Nine different companies joined members of the House Select Committee on China at a press conference on Wednesday to talk about their battles with “China trade cheats” that have cost them a fortune. Most of them closed factories, or rolled back investment. Despite tariffs and anti-dumping (AD/CVD) trade case victories, the battle continues.
In a House Oversight subcommittee hearing on Feb. 26, the Inflation Reduction Act (IRA) was hit with the usual swipes from detractors, with some calling it the “green scam”, but China’s solar company benefits were never mentioned.
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
Lutnick has faced adversity before. He lost his parents when he was just 18 and later rebuilt Cantor Fitzgerald after the September 11, 2001 terrorist attacks claimed the lives of over 600 staff and key executives, including his own brother. Now, as Commerce Secretary, he must tell trade ministers that the United States is seeking a different kind of relationship.
Industrial Policy for the United States seeks to list all of the tools a country can use to improve its industrial base and entice businesses to invest in manufacturing. If these tools are deployed, the authors argue, the results will be good for local economies and labor.
The duties impact several major Chinese solar brands, including Jinko Solar and Trina Solar, as well as Vietnamese manufacturers that Commerce believes have been circumventing tariffs by importing components from mainland China for final assembly.
Varoufakis’ essay is a must-read for CPA members curious about what a former G-20 Finance Minister (the equivalent of our Treasury Secretary) thinks about the dollar.
President Trump released his “Fair and Reciprocal Trade” memo on Thursday, calling into question whether these new proposed tariffs will be permanent like the China Section 301s or quickly removed once a country “reciprocates” in kind.
It’s the most well-known secret on Capitol Hill: China owns the American generic drug supply chain. Basic thyroid or blood pressure medications might finally be put into pill form in an Indian lab and sold under an Indian brand like Cipla. But the organic compounds, or key starting materials, mostly come from China.
China is forecast to account for 45% of the world’s global industrial production by 2030. That growth comes at the expense of the West, which is projected to drop to 11% of global production in the next five years.
